Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Enno Veerman

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Anatomy

Procedures

Physiology

Bacterial Adhesion

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Oudhoff Menno J; Kroeze Kim L; Nazmi Kamran; van den Keijbus Petra A M; van 't Hof Wim; Fernandez-Borja Mar; Hordijk Peter L; Gibbs Susan; Bolscher Jan G M; Veerman Enno C I
Structure-activity analysis of histatin, a potent wound healing peptide from human saliva: cyclization of histatin potentiates molar activity 1,000-fold.
Leito Jelani T D; Ligtenberg Antoon J M; Nazmi Kamran; Veerman Enno C I
Identification of salivary components that induce transition of hyphae to yeast in Candida albicans.
Oudhoff M J; van den Keijbus P A M; Kroeze K L; Nazmi K; Gibbs S; Bolscher J G M; Veerman E C I
Histatins enhance wound closure with oral and non-oral cells.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Enno Veerman (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Oudhoff Menno J; Kroeze Kim L; Nazmi Kamran; van den Keijbus Petra A M; van 't Hof Wim; Fernandez-Borja Mar; Hordijk Peter L; Gibbs Susan; Bolscher Jan G M; Veerman Enno C I
Structure-activity analysis of histatin, a potent wound healing peptide from human saliva: cyclization of histatin potentiates molar activity 1,000-fold.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2009;23(11):3928-35.
2009: Leito Jelani T D; Ligtenberg Antoon J M; Nazmi Kamran; Veerman Enno C I
Identification of salivary components that induce transition of hyphae to yeast in Candida albicans.
FEMS yeast research 2009;9(7):1102-10.
2009: Oudhoff M J; van den Keijbus P A M; Kroeze K L; Nazmi K; Gibbs S; Bolscher J G M; Veerman E C I
Histatins enhance wound closure with oral and non-oral cells.
Journal of dental research 2009;88(9):846-50.
2009: Silva Denise G; Stevens Roy H; Macedo Jacyara M B; Albano Rodolpho M; Falabella Marcio E V; Veerman Enno C I; Tinoco Eduardo M B
Detection of cytotoxin genotypes of Helicobacter pylori in stomach, saliva and dental plaque.
Archives of oral biology 2009;54(7):684-8.
2009: Molhoek E Margo; den Hertog Alice L; de Vries Anne-Marij B C; Nazmi Kamran; Veerman Enno C I; Hartgers Franca C; Yazdanbakhsh Maria; Bikker Floris J; van der Kleij Desiree
Structure-function relationship of the human antimicrobial peptide LL-37 and LL-37 fragments in the modulation of TLR responses.
Biological chemistry 2009;390(4):295-303.
2009: Silva Denise G; Stevens Roy H; Macedo Jacyara M B; Hirata Raphael; Pinto Amanda C; Alves Luciano M; Veerman Enno C I; Tinoco Eduardo M B
Higher levels of salivary MUC5B and MUC7 in individuals with gastric diseases who harbor Helicobacter pylori.
Archives of oral biology 2009;54(1):86-90.
2009: Bolscher Jan G M; Adão Regina; Nazmi Kamran; van den Keybus Petra A M; van 't Hof Wim; Nieuw Amerongen Arie V; Bastos Margarida; Veerman Enno C I
Bactericidal activity of LFchimera is stronger and less sensitive to ionic strength than its constituent lactoferricin and lactoferrampin peptides.
Biochimie 2009;91(1):123-32.
2008: Oudhoff Menno J; Bolscher Jan G M; Nazmi Kamran; Kalay Hakan; van 't Hof Wim; Amerongen Arie V Nieuw; Veerman Enno C I
Histatins are the major wound-closure stimulating factors in human saliva as identified in a cell culture assay.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2008;22(11):3805-12.
2008: Bruins G J H; Vissink A; Veerman E C I; van Nieuw Amerongen A
[Influence of sports on saliva]
Nederlands tijdschrift voor tandheelkunde 2008;115(9):467-73.
2008: Leito Jelani T D; Ligtenberg Antoon J M; Nazmi Kamran; de Blieck-Hogervorst Jolanda M A; Veerman Enno C I; Nieuw Amerongen Arie V
A common binding motif for various bacteria of the bacteria-binding peptide SRCRP2 of DMBT1/gp-340/salivary agglutinin.
Biological chemistry 2008;389(9):1193-200.
2008: Luque-Ortega Juan Román; van't Hof Wim; Veerman Enno C I; Saugar José M; Rivas Luis
Human antimicrobial peptide histatin 5 is a cell-penetrating peptide targeting mitochondrial ATP synthesis in Leishmania.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2008;22(6):1817-28.
2007: Ligtenberg Antoon J M; Veerman Enno C I; Nieuw Amerongen Arie V; Mollenhauer Jan
Salivary agglutinin/glycoprotein-340/DMBT1: a single molecule with variable composition and with different functions in infection, inflammation and cancer.
Biological chemistry 2007;388(12):1275-89.
2007: Vissink A; Veerman E C I; van Nieuw Amerongen A
[Saliva diagnosis: the future becomes the present reality]
Nederlands tijdschrift voor tandheelkunde 2007;114(11):468-73.
2007: Welling Mick M; Brouwer Carlo P J M; van 't Hof Wim; Veerman Enno C I; Amerongen Arie V Nieuw
Histatin-derived monomeric and dimeric synthetic peptides show strong bactericidal activity towards multidrug-resistant Staphylococcus aureus in vivo.
Antimicrobial agents and chemotherapy 2007;51(9):3416-9.
2007: Veerman Enno C I; Valentijn-Benz Marianne; Nazmi Kamran; Ruissen Anita L A; Walgreen-Weterings Els; van Marle Jan; Doust Alexander B; van't Hof Wim; Bolscher Jan G M; Amerongen Arie V Nieuw
Energy depletion protects Candida albicans against antimicrobial peptides by rigidifying its cell membrane.
The Journal of biological chemistry 2007;282(26):18831-41.
2007: Engelen Lina; van den Keybus Petra A M; de Wijk René A; Veerman Enno C I; Amerongen Arie V Nieuw; Bosman Frits; Prinz Jon F; van der Bilt Andries
The effect of saliva composition on texture perception of semi-solids.
Archives of oral biology 2007;52(6):518-25.
2007: Ligtenberg Antoon J M; de Soet Johannes J; Veerman Enno C I; Amerongen Arie V Nieuw
Oral diseases: from detection to diagnostics.
Annals of the New York Academy of Sciences 2007;1098():200-3.
2007: Nieuw Amerongen Arie V; Ligtenberg Antoon J M; Veerman Enno C I
Implications for diagnostics in the biochemistry and physiology of saliva.
Annals of the New York Academy of Sciences 2007;1098():1-6.
2007: Bots C P; Brand H S; Veerman E C I; Valentijn-Benz M; Henskens Y M C; Valentijn R M; Vos P F; Bijlsma J A; Ter Wee P M; Van Amerongen B M; Nieuw Amerongen A V
Acute effects of hemodialysis on salivary flow rate and composition.
Clinical nephrology 2007;67(1):25-31.
2007: Bots C P; Brand H S; Poorterman J H G; van Amerongen B M; Valentijn-Benz M; Veerman E C I; ter Wee P M; Nieuw Amerongen A V
Oral and salivary changes in patients with end stage renal disease (ESRD): a two year follow-up study.
British dental journal 2007;202(2):E3.
2006: den Hertog Alice L; van Marle Jan; Veerman Enno C I; Valentijn-Benz Marianne; Nazmi Kamran; Kalay Hakan; Grün Christian H; Van't Hof Wim; Bolscher Jan G M; Nieuw Amerongen Arie V
The human cathelicidin peptide LL-37 and truncated variants induce segregation of lipids and proteins in the plasma membrane of Candida albicans.
Biological chemistry 2006;387(10-11):1495-502.
2006: Groot Fedde; Sanders Rogier W; ter Brake Olivier; Nazmi Kamran; Veerman Enno C I; Bolscher Jan G M; Berkhout Ben
Histatin 5-derived peptide with improved fungicidal properties enhances human immunodeficiency virus type 1 replication by promoting viral entry.
Journal of virology 2006;80(18):9236-43.
2006: Brand H S; Bruins M L; Veerman E C I; Nieuw Amerongen A V
Secretion rate and amylase concentration of whole saliva after consumption of beer.
International journal of dental hygiene 2006;4(3):160-1.
2006: van der Kraan Marieke I A; Nazmi Kamran; van 't Hof Wim; Amerongen Arie V Nieuw; Veerman Enno C I; Bolscher Jan G M
Distinct bactericidal activities of bovine lactoferrin peptides LFampin 268-284 and LFampin 265-284: Asp-Leu-Ile makes a difference.
Biochemistry and cell biology = Biochimie et biologie cellulaire 2006;84(3):358-62.
2006: Szynol A; de Haard J J W; Veerman E C; de Soet J J; van Nieuw Amerongen A V
Design of a peptibody consisting of the antimicrobial peptide dhvar5 and a llama variable heavy-chain antibody fragment.
Chemical biology & drug design 2006;67(6):425-31.
2006: van Nieuw Ameronpn A; Veerman E C I; Brand H S; Vissink A
[Saliva: more than just a factor in oral health]
Nederlands tijdschrift voor tandheelkunde 2006;113(5):176-81.
2006: Gabriel Matthias; Nazmi Kamran; Veerman Enno C; Nieuw Amerongen Arie V; Zentner Andrej
Preparation of LL-37-grafted titanium surfaces with bactericidal activity.
Bioconjugate chemistry 2006;17(2):548-50.
2006: Bots C P; Poorterman J H G; Brand H S; Kalsbeek H; van Amerongen B M; Veerman E C I; Nieuw Amerongen A V
The oral health status of dentate patients with chronic renal failure undergoing dialysis therapy.
Oral diseases 2006;12(2):176-80.
2006: Bolscher Jan G M; van der Kraan Marieke I A; Nazmi Kamran; Kalay Hakan; Grün Christian H; Van't Hof Wim; Veerman Enno C I; Nieuw Amerongen Arie V
A one-enzyme strategy to release an antimicrobial peptide from the LFampin-domain of bovine lactoferrin.
Peptides 2006;27(1):1-9.
2005: van der Kraan Marieke I A; van der Made Christel; Nazmi Kamran; van't Hof Wim; Groenink Jasper; Veerman Enno C I; Bolscher Jan G M; Nieuw Amerongen Arie V
Effect of amino acid substitutions on the candidacidal activity of LFampin 265-284.
Peptides 2005;26(11):2093-7.
2005: Veerman E C I
[Mopping with open faucets: immune system in sputum]
Nederlands tijdschrift voor tandheelkunde 2005;112(10):390-1.
2005: van der Kraan Marieke I A; van Marle Jan; Nazmi Kamran; Groenink Jasper; van 't Hof Wim; Veerman Enno C I; Bolscher Jan G M; Nieuw Amerongen Arie V
Ultrastructural effects of antimicrobial peptides from bovine lactoferrin on the membranes of Candida albicans and Escherichia coli.
Peptides 2005;26(9):1537-42.
2005: den Hertog Alice L; van Marle Jan; van Veen Henk A; Van't Hof Wim; Bolscher Jan G M; Veerman Enno C I; Nieuw Amerongen Arie V
Candidacidal effects of two antimicrobial peptides: histatin 5 causes small membrane defects, but LL-37 causes massive disruption of the cell membrane.
The Biochemical journal 2005;388(Pt 2):689-95.
2005: Bots Casper P; Brand Henk S; Veerman Enno C I; Valentijn-Benz Marianne; Van Amerongen Barbara M; Nieuw Amerongen Arie V; Valentijn Robert M; Vos Pieter F; Bijlsma Joost A; Bezemer Pieter D; ter Wee Piet M
The management of xerostomia in patients on haemodialysis: comparison of artificial saliva and chewing gum.
Palliative medicine 2005;19(3):202-7.
2005: Bots Casper P; Brand Henk S; Veerman Enno C I; Korevaar Johanna C; Valentijn-Benz Marianne; Bezemer Pieter D; Valentijn Robert M; Vos Pieter F; Bijlsma Joost A; ter Wee Piet M; Van Amerongen Barbara M; Nieuw Amerongen Arie V
Chewing gum and a saliva substitute alleviate thirst and xerostomia in patients on haemodialysis.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2005;20(3):578-84.
2005: van der Kraan Marieke I A; Nazmi Kamran; Teeken Afke; Groenink Jasper; van 't Hof Wim; Veerman Enno C I; Bolscher Jan G M; Nieuw Amerongen Arie V
Lactoferrampin, an antimicrobial peptide of bovine lactoferrin, exerts its candidacidal activity by a cluster of positively charged residues at the C-terminus in combination with a helix-facilitating N-terminal part.
Biological chemistry 2005;386(2):137-42.
2004: Teeuw Wijnand; Bosch Jos A; Veerman Enno C I; Amerongen Arie V Nieuw
Neuroendocrine regulation of salivary IgA synthesis and secretion: implications for oral health.
Biological chemistry 2004;385(12):1137-46.
2004: Bikker Floris J; Ligtenberg Antoon J M; End Caroline; Renner Marcus; Blaich Stephanie; Lyer Stefan; Wittig Rainer; van't Hof Wim; Veerman Enno C I; Nazmi Kamran; de Blieck-Hogervorst Jolanda M A; Kioschis Petra; Nieuw Amerongen Arie V; Poustka Annemarie; Mollenhauer Jan
Bacteria binding by DMBT1/SAG/gp-340 is confined to the VEVLXXXXW motif in its scavenger receptor cysteine-rich domains.
The Journal of biological chemistry 2004;279(46):47699-703.
2004: Bots Casper P; Brand Henk S; Veerman Enno C I; Valentijn-Benz Marianne; Van Amerongen Barbara M; Valentijn Robert M; Vos Pieter F; Bijlsma Joost A; Bezemer Pieter D; Ter Wee Piet M; Amerongen Arie V Nieuw
Interdialytic weight gain in patients on hemodialysis is associated with dry mouth and thirst.
Kidney international 2004;66(4):1662-8.
2004: Ligtenberg Antoon J M; Bikker Floris J; De Blieck-Hogervorst Jolanda M A; Veerman Enno C I; Nieuw Amerongen Arie V
Binding of salivary agglutinin to IgA.
The Biochemical journal 2004;383(Pt 1):159-64.
2004: van Nieuw Amerongen A; Veerman E C I; Vissink A
[Research methods in dentistry 2. Methods for determining the flow rate of saliva]
Nederlands tijdschrift voor tandheelkunde 2004;111(7):276-82.
2004: Veerman Enno C I; Nazmi Kamran; Van't Hof Wim; Bolscher Jan G M; Den Hertog Alice L; Nieuw Amerongen Arie V
Reactive oxygen species play no role in the candidacidal activity of the salivary antimicrobial peptide histatin 5.
The Biochemical journal 2004;381(Pt 2):447-52.
2004: Bots C P; Brand H S; Veerman E C I; van Amerongen B M; Nieuw Amerongen A V
Preferences and saliva stimulation of eight different chewing gums.
International dental journal 2004;54(3):143-8.
2004: Van Nieuw Amerongen A; Bolscher J G M; Veerman E C I
Salivary proteins: protective and diagnostic value in cariology?
Caries research 2004;38(3):247-53.
2004: Den Hertog Alice L; Wong Fong Sang Harro W; Kraayenhof Ruud; Bolscher Jan G M; Van't Hof Wim; Veerman Enno C I; Nieuw Amerongen Arie V
Interactions of histatin 5 and histatin 5-derived peptides with liposome membranes: surface effects, translocation and permeabilization.
The Biochemical journal 2004;379(Pt 3):665-72.
2004: van Nieuw Amerongen A; van den Keijbus P A; Veerman E C
[Influence of teas with fruit aroma and ice teas on pH and buffer capacity of saliva]
Nederlands tijdschrift voor tandheelkunde 2004;111(3):80-4.
2004: van der Kraan Marieke I A; Groenink Jasper; Nazmi Kamran; Veerman Enno C I; Bolscher Jan G M; Nieuw Amerongen Arie V
Lactoferrampin: a novel antimicrobial peptide in the N1-domain of bovine lactoferrin.
Peptides 2004;25(2):177-83.
2004: Vissink Arjan; Burlage Fred R; Spijkervet Fred K L; Veerman Enno C I; Nieuw Amerongen Arie V
Prevention and treatment of salivary gland hypofunction related to head and neck radiation therapy and chemotherapy.
Supportive cancer therapy 2004;1(2):111-8.
2003: van Gils P C; Brand H S; Timmerman M F; Veerman E C I; van der Velden U; van der Weijden G A
Salivary cystatin activity and cystatin C in experimental gingivitis in non-smokers.
Journal of clinical periodontology 2003;30(10):882-6.
2003: Groenink J; Ruissen A L A; Lowies D; van 't Hof W; Veerman E C I; Nieuw Amerongen A V
Degradation of antimicrobial histatin-variant peptides in Staphylococcus aureus and Streptococcus mutans.
Journal of dental research 2003;82(9):753-7.
2003: Bosch Jos A; Turkenburg Marjolein; Nazmi Kamran; Veerman Enno C I; de Geus Eco J C; Nieuw Amerongen Arie V
Stress as a determinant of saliva-mediated adherence and coadherence of oral and nonoral microorganisms.
Psychosomatic medicine 2003;65(4):604-12.
2003: Dennesen Paul; Veerman Enno; van Nieuw Amerongen Arie; Jacobs Jan; Kessels Alphons; van der Keybus Petra; Ramsay Graham; van der Ven André
High levels of sulfated mucins in bronchoalveolar lavage fluid of ICU patients with ventilator-associated pneumonia.
Intensive care medicine 2003;29(5):715-9.
2003: Veerman E C I; van den Keijbus P A M; Nazmi K; Vos W; van der Wal J E; Bloemena E; Bolscher J G M; Amerongen A V Nieuw
Distinct localization of MUC5B glycoforms in the human salivary glands.
Glycobiology 2003;13(5):363-6.
2003: Nieuw Amerongen A V; Veerman E C I
Current therapies for xerostomia and salivary gland hypofunction associated with cancer therapies.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2003;11(4):226-31.
2003: Bosch J A; Veerman E C I; Turkenburg M; Hartog K; Bolscher J G M; Nieuw Amerongen A V
A rapid solid-phase fluorimetric assay for measuring bacterial adherence, using DNA-binding stains.
Journal of microbiological methods 2003;53(1):51-6.
2003: Bosch Jos A; de Geus Eco J C; Veerman Enno C I; Hoogstraten Johan; Nieuw Amerongen Arie V
Innate secretory immunity in response to laboratory stressors that evoke distinct patterns of cardiac autonomic activity.
Psychosomatic medicine 2003;65(2):245-58.
2003: Dennesen Paul; van der Ven André; Vlasveld Mariel; Lokker Linka; Ramsay Graham; Kessels Alphons; van den Keijbus Petra; van Nieuw Amerongen Arie; Veerman Enno
Inadequate salivary flow and poor oral mucosal status in intubated intensive care unit patients.
Critical care medicine 2003;31(3):781-6.
2003: Ruissen Anita L A; Groenink Jasper; Krijtenberg Patricia; Walgreen-Weterings Els; van 't Hof Wim; Veerman Enno C I; Nieuw Amerongen Arie V
Internalisation and degradation of histatin 5 by Candida albicans.
Biological chemistry 2003;384(1):183-90.
2002: Hoek G Henk; Brand Henk S; Veerman Enno C I; Amerongen Arie V Nieuw
Toothbrushing affects the protein composition of whole saliva.
European journal of oral sciences 2002;110(6):480-1.
2002: Ruissen Anita L A; Groenink Jasper; Lommerse Cock H; Van 't Hof Wim; Veerman Enno C I; Nieuw Amerongen Arie V
Effects of carbohydrate polymers applicable in saliva substitutes on the anti-Candida activity of a histatin-derived peptide.
Archives of oral biology 2002;47(11):749-56.
2002: Van Steijn G J; Amerongen A V Nieuw; Veerman E C I; Kasanmoentalib S; Overdijk B
Effect of periodontal treatment on the activity of chitinase in whole saliva of periodontitis patients.
Journal of periodontal research 2002;37(4):245-9.
2002: Ruissen A L A; Groenink J; Van't Hof W; Walgreen-Weterings E; van Marle J; van Veen H A; Voorhout W F; Veerman E C I; Nieuw Amerongen A V
Histatin 5 and derivatives. Their localization and effects on the ultra-structural level.
Peptides 2002;23(8):1391-9.
2002: Bikker Floris J; Ligtenberg Antoon J M; Nazmi Kamran; Veerman Enno C I; van't Hof Wim; Bolscher Jan G M; Poustka Annemarie; Nieuw Amerongen Arie V; Mollenhauer Jan
Identification of the bacteria-binding peptide domain on salivary agglutinin (gp-340/DMBT1), a member of the scavenger receptor cysteine-rich superfamily.
The Journal of biological chemistry 2002;277(35):32109-15.
2002: Bolscher Jan G M; Nazmi Kamran; Ran Leonie J; van Engelenburg Frank A C; Schuitemaker Hanneke; Veerman Enno C I; Nieuw Amerongen Arie V
Inhibition of HIV-1 IIIB and clinical isolates by human parotid, submandibular, sublingual and palatine saliva.
European journal of oral sciences 2002;110(2):149-56.
2002: Bikker F J; Ligtenberg A J M; van der Wal J E; van den Keijbus P A M; Holmskov U; Veerman E C I; Nieuw Amerongen A V
Immunohistochemical detection of salivary agglutinin/gp-340 in human parotid, submandibular, and labial salivary glands.
Journal of dental research 2002;81(2):134-9.
2002: Amerongen A V Nieuw; Veerman E C I
Saliva--the defender of the oral cavity.
Oral diseases 2002;8(1):12-22.
2002: Bosch Jos A; Ring Christopher; de Geus Eco J C; Veerman Enno C I; Amerongen Arie V Nieuw
Stress and secretory immunity.
International review of neurobiology 2002;52():213-53.
2001: Lie M A; Loos B G; Henskens Y M; Timmerman M F; Veerman E C; van der Velden U; van der Weijden G A
Salivary cystatin activity and cystatin C in natural and experimental gingivitis in smokers and non-smokers.
Journal of clinical periodontology 2001;28(10):979-84.
2001: Ligtenberg T J; Bikker F J; Groenink J; Tornoe I; Leth-Larsen R; Veerman E C; Nieuw Amerongen A V; Holmskov U
Human salivary agglutinin binds to lung surfactant protein-D and is identical with scavenger receptor protein gp-340.
The Biochemical journal 2001;359(Pt 1):243-8.
2001: Bosch J A; de Geus E J; Kelder A; Veerman E C; Hoogstraten J; Amerongen A V
Differential effects of active versus passive coping on secretory immunity.
Psychophysiology 2001;38(5):836-46.
2001: Ruissen A L; Groenink J; Helmerhorst E J; Walgreen-Weterings E; Van't Hof W; Veerman E C; Nieuw Amerongen A V
Effects of histatin 5 and derived peptides on Candida albicans.
The Biochemical journal 2001;356(Pt 2):361-8.
2001: van 't Hof W; Veerman E C; Helmerhorst E J; Amerongen A V
Antimicrobial peptides: properties and applicability.
Biological chemistry 2001;382(4):597-619.
2001: Helmerhorst E J; van't Hof W; Breeuwer P; Veerman E C; Abee T; Troxler R F; Amerongen A V; Oppenheim F G
Characterization of histatin 5 with respect to amphipathicity, hydrophobicity, and effects on cell and mitochondrial membrane integrity excludes a candidacidal mechanism of pore formation.
The Journal of biological chemistry 2001;276(8):5643-9.
2000: van't Hof W; Reijnders I M; Helmerhorst E J; Walgreen-Weterings E; Simoons-Smit I M; Veerman E C; Amerongen A V
Synergistic effects of low doses of histatin 5 and its analogues on amphotericin B anti-mycotic activity.
Antonie van Leeuwenhoek 2000;78(2):163-9.
2000: Elving G J; van der Mei H C; Busscher H J; van Nieuw Amerongen A; Veerman E C; van Weissenbruch R; Albers F W
Antimicrobial activity of synthetic salivary peptides against voice prosthetic microorganisms.
The Laryngoscope 2000;110(2 Pt 1):321-4.
2000: Bosch J A; de Geus E J; Ligtenberg T J; Nazmi K; Veerman E C; Hoogstraten J; Amerongen A V
Salivary MUC5B-mediated adherence (ex vivo) of Helicobacter pylori during acute stress.
Psychosomatic medicine 2000;62(1):40-9.
2000: Ligtenberg A J; Veerman E C; Nieuw Amerongen A V
A role for Lewis a antigens on salivary agglutinin in binding to Streptococcus mutans.
Antonie van Leeuwenhoek 2000;77(1):21-30.
1999: Groenink J; Walgreen-Weterings E; van 't Hof W; Veerman E C; Nieuw Amerongen A V
Cationic amphipathic peptides, derived from bovine and human lactoferrins, with antimicrobial activity against oral pathogens.
FEMS microbiology letters 1999;179(2):217-22.
1999: Van Steijn G J; Amerongen A V; Veerman E C; Kasanmoentalib S; Overdijk B
Chitinase in whole and glandular human salivas and in whole saliva of patients with periodontal inflammation.
European journal of oral sciences 1999;107(5):328-37.
1999: van der Reijden W A; Vissink A; Veerman E C; Amerongen A V
Treatment of oral dryness related complaints (xerostomia) in Sjögren's syndrome.
Annals of the rheumatic diseases 1999;58(8):465-74.
1999: Bolscher J G; Groenink J; van der Kwaak J S; van den Keijbus P A; van 't Hof W; Veerman E C; Nieuw Amerongen A V
Detection and quantification of MUC7 in submandibular, sublingual, palatine, and labial saliva by anti-peptide antiserum.
Journal of dental research 1999;78(7):1362-9.
1999: Helmerhorst E J; Hodgson R; van 't Hof W; Veerman E C; Allison C; Nieuw Amerongen A V
The effects of histatin-derived basic antimicrobial peptides on oral biofilms.
Journal of dental research 1999;78(6):1245-50.
1999: Ruissen A L; van der Reijden W A; van't Hof W; Veerman E C; Nieuw Amerongen A V
Evaluation of the use of xanthan as vehicle for cationic antifungal peptides.
Journal of controlled release : official journal of the Controlled Release Society 1999;60(1):49-56.
1999: Groenink J; Walgreen-Weterings E; Nazmi K; Bolscher J G; Veerman E C; van Winkelhoff A J; Nieuw Amerongen A V
Salivary lactoferrin and low-Mr mucin MG2 in Actinobacillus actinomycetemcomitans-associated periodontitis.
Journal of clinical periodontology 1999;26(5):269-75.
1999: Helmerhorst E J; Reijnders I M; van 't Hof W; Veerman E C; Nieuw Amerongen A V
A critical comparison of the hemolytic and fungicidal activities of cationic antimicrobial peptides.
FEBS letters 1999;449(2-3):105-10.
1999: Helmerhorst E J; Breeuwer P; van't Hof W; Walgreen-Weterings E; Oomen L C; Veerman E C; Amerongen A V; Abee T
The cellular target of histatin 5 on Candida albicans is the energized mitochondrion.
The Journal of biological chemistry 1999;274(11):7286-91.
1999: Helmerhorst E J; Reijnders I M; van't Hof W; Simoons-Smit I; Veerman E C; Amerongen A V
Amphotericin B- and fluconazole-resistant Candida spp., Aspergillus fumigatus, and other newly emerging pathogenic fungi are susceptible to basic antifungal peptides.
Antimicrobial agents and chemotherapy 1999;43(3):702-4.
1998: Blankenvoorde M F; van't Hof W; Walgreen-Weterings E; van Steenbergen T J; Brand H S; Veerman E C; Nieuw Amerongen A V
Cystatin and cystatin-derived peptides have antibacterial activity against the pathogen Porphyromonas gingivalis.
Biological chemistry 1998;379(11):1371-5.
1998: Groenink J; Veerman E C; Zandvoort M S; Van der Mei H C; Busscher H J; Nieuw Amerongen A V
The interaction between saliva and Actinobacillus actinomycetemcomitans influenced by the zeta potential.
Antonie van Leeuwenhoek 1998;73(3):279-88.
1998: Namavar F; Sparrius M; Veerman E C; Appelmelk B J; Vandenbroucke-Grauls C M
Neutrophil-activating protein mediates adhesion of Helicobacter pylori to sulfated carbohydrates on high-molecular-weight salivary mucin.
Infection and immunity 1998;66(2):444-7.
1998: Nieuw Amerongen A V; Bolscher J G; Bloemena E; Veerman E C
Sulfomucins in the human body.
Biological chemistry 1998;379(1):1-18.
1998: Veerman E C; Go K G; Molenaar W M; Amerongen A V; Vissink A
On the chemical characterization of colloid cyst contents.
Acta neurochirurgica 1998;140(4):303-6; discussion 306-7.
1997: Blankenvoorde M F; Henskens Y M; van der Weijden G A; van den Keijbus P A; Veerman E C; Nieuw Amerongen A V
Cystatin A in gingival crevicular fluid of periodontal patients.
Journal of periodontal research 1997;32(7):583-8.
1997: Veerman E C; Bank C M; Namavar F; Appelmelk B J; Bolscher J G; Nieuw Amerongen A V
Sulfated glycans on oral mucin as receptors for Helicobacter pylori.
Glycobiology 1997;7(6):737-43.
1997: Helmerhorst E J; Van't Hof W; Veerman E C; Simoons-Smit I; Nieuw Amerongen A V
Synthetic histatin analogues with broad-spectrum antimicrobial activity.
The Biochemical journal 1997;326 ( Pt 1)():39-45.
1997: Schenkels L C; Walgreen-Weterings E; Oomen L C; Bolscher J G; Veerman E C; Nieuw Amerongen A V
In vivo binding of the salivary glycoprotein EP-GP (identical to GCDFP-15) to oral and non-oral bacteria detection and identification of EP-GP binding species.
Biological chemistry 1997;378(2):83-8.
1997: Veerman E C; Bolscher J G; Appelmelk B J; Bloemena E; van den Berg T K; Nieuw Amerongen A V
A monoclonal antibody directed against high M(r) salivary mucins recognizes the SO3-3Gal beta 1-3GlcNAc moiety of sulfo-Lewis(a): a histochemical survey of human and rat tissue.
Glycobiology 1997;7(1):37-43.
1997: van't Hof W; Blankenvoorde M F; Veerman E C; Amerongen A V
The salivary lipocalin von Ebner's gland protein is a cysteine proteinase inhibitor.
The Journal of biological chemistry 1997;272(3):1837-41.
1997: van der Reijden W A; Buijs M J; Damen J J; Veerman E C; ten Cate J M; Nieuw Amerongen A V
Influence of polymers for use in saliva substitutes on de- and remineralization of enamel in vitro.
Caries research 1997;31(3):216-23.
1996: Blankenvoorde M F; Henskens Y M; van't Hof W; Veerman E C; Nieuw Amerongen A V
Inhibition of the growth and cysteine proteinase activity of Porphyromonas gingivalis by human salivary cystatin S and chicken cystatin.
Biological chemistry 1996;377(12):847-50.
1996: Veerman E C; van den Keybus P A; Vissink A; Nieuw Amerongen A V
Human glandular salivas: their separate collection and analysis.
European journal of oral sciences 1996;104(4 ( Pt 1)):346-52.
1996: van der Reijden W A; van der Kwaak J S; Veerman E C; Nieuw Amerongen A V
Analysis of the concentration and output of whole salivary constituents in patients with Sjögren's syndrome.
European journal of oral sciences 1996;104(4 ( Pt 1)):335-40.
1996: Henskens Y M; Strooker H; van den Keijbus P A; Veerman E C; Nieuw Amerongen A V
Salivary protein composition in epileptic patients on different medications.
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 1996;25(7):360-6.
1996: Groenink J; Ligtenberg A J; Veerman E C; Bolscher J G; Nieuw Amerongen A V
Interaction of the salivary low-molecular-weight mucin (MG2) with Actinobacillus actinomycetemcomitans.
Antonie van Leeuwenhoek 1996;70(1):79-87.
1996: Henskens Y M; van der Weijden F A; van den Keijbus P A; Veerman E C; Timmerman M F; van der Velden U; Amerongen A V
Effect of periodontal treatment on the protein composition of whole and parotid saliva.
Journal of periodontology 1996;67(3):205-12.
1996: Henskens Y M; Veerman E C; Nieuw Amerongen A V
Cystatins in health and disease.
Biological chemistry Hoppe-Seyler 1996;377(2):71-86.
1996: Henskens Y M; van den Keijbus P A; Veerman E C; Van der Weijden G A; Timmerman M F; Snoek C M; Van der Velden U; Nieuw Amerongen A V
Protein composition of whole and parotid saliva in healthy and periodontitis subjects. Determination of cystatins, albumin, amylase and IgA.
Journal of periodontal research 1996;31(1):57-65.
1996: van der Reijden W A; van der Kwaak H; Vissink A; Veerman E C; Amerongen A V
Treatment of xerostomia with polymer-based saliva substitutes in patients with Sjögren's syndrome.
Arthritis and rheumatism 1996;39(1):57-63.
1995: Amerongen A V; Bolscher J G; Veerman E C
Salivary mucins: protective functions in relation to their diversity.
Glycobiology 1995;5(8):733-40.
1995: van Nieuw Amerongen A; Veerman E C
[Dental erosion and nutrition]
Nederlands tijdschrift voor tandheelkunde 1995;102(11):443-5.
1995: van Nieuw Amerongen A; Veerman E C
[Role of saliva during mastication]
Nederlands tijdschrift voor tandheelkunde 1995;102(11):441-2.
1995: Schenkels L C; Veerman E C; Nieuw Amerongen A V
EP-GP and the lipocalin VEGh, two different human salivary 20-kDa proteins.
Journal of dental research 1995;74(9):1543-50.
1995: Bolscher J; Veerman E; Van Nieuw Amerongen A; Tulp A; Verwoerd D
Distinct populations of high-M(r) mucins secreted by different human salivary glands discriminated by density-gradient electrophoresis.
The Biochemical journal 1995;309 ( Pt 3)():801-6.
1995: Veerman E C; Ligtenberg A J; Schenkels L C; Walgreen-Weterings E; Nieuw Amerongen A V
Binding of human high-molecular-weight salivary mucins (MG1) to Hemophilus parainfluenzae.
Journal of dental research 1995;74(1):351-7.
1995: Schenkels L C; Veerman E C; Nieuw Amerongen A V
Biochemical composition of human saliva in relation to other mucosal fluids.
Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists 1995;6(2):161-75.
1994: Van der Reijden W A; Veerman E C; Nieuw Amerongen A V
Rheological properties of commercially available polysaccharides with potential use in saliva substitutes.
Biorheology 1994;31(6):631-42.
1994: Henskens Y M; Veerman E C; Mantel M S; van der Velden U; Nieuw Amerongen A V
Cystatins S and C in human whole saliva and in glandular salivas in periodontal health and disease.
Journal of dental research 1994;73(10):1606-14.
1994: Schenkels L C; Schaller J; Walgreen-Weterings E; Schadee-Eestermans I L; Veerman E C; Nieuw Amerongen A V
Identity of human extra parotid glycoprotein (EP-GP) with secretory actin binding protein (SABP) and its biological properties.
Biological chemistry Hoppe-Seyler 1994;375(9):609-15.
1994: van Nieuw Amerongen A; Veerman E C; Abraham-Inpijn L; van Steenbergen T J; van Winkelhoff A J
[Halitosis (fetor ex ore). A review]
Nederlands tijdschrift voor tandheelkunde 1994;101(1):10-4; quiz 15, 22.
1993: Schenkels L C; Ligtenberg A J; Veerman E C; Van Nieuw Amerongen A
Interaction of the salivary glycoprotein EP-GP with the bacterium Streptococcus salivarius HB.
Journal of dental research 1993;72(12):1559-65.
1993: Nieuw Amerongen A V; Strooker H; Henskens Y M; Ligtenberg A J; Veerman E C
Biochemical changes in (glyco)proteins of saliva of epileptic patients.
Annals of the New York Academy of Sciences 1993;694():283-5.
1993: Henskens Y M; Van der Velden U; Veerman E C; Nieuw Amerongen A V
Cystatin C levels of whole saliva are increased in periodontal patients.
Annals of the New York Academy of Sciences 1993;694():280-2.
1993: van der Reijden W A; Veerman E C; van Nieuw Amerongen A
[Saliva and saliva substitutes]
Nederlands tijdschrift voor tandheelkunde 1993;100(8):351-4.
1993: van der Reijden W A; Veerman E C; Amerongen A V
Shear rate dependent viscoelastic behavior of human glandular salivas.
Biorheology 1993;30(2):141-52.
1993: Henskens Y M; van der Velden U; Veerman E C; Nieuw Amerongen A V
Protein, albumin and cystatin concentrations in saliva of healthy subjects and of patients with gingivitis or periodontitis.
Journal of periodontal research 1993;28(1):43-8.
1993: Ligtenberg A J; Walgreen-Weterings E; Veerman E C; de Graaff J; Nieuw Amerongen A V
Adherence of Streptococcus gordonii HG 222 in the presence of saliva.
Antonie van Leeuwenhoek 1993;64(1):39-45.
1992: Ligtenberg A J; Walgreen-Weterings E; Veerman E C; de Soet J J; de Graaff J; Amerongen A V
Influence of saliva on aggregation and adherence of Streptococcus gordonii HG 222.
Infection and immunity 1992;60(9):3878-84.
1992: Veerman E C; van den Keybus P A; Valentijn-Benz M; Nieuw Amerongen A V
Isolation of different high-Mr mucin species from human whole saliva.
The Biochemical journal 1992;283 ( Pt 3)():807-11.
1992: Nieuw Amerongen A V; Strooker H; Oderkerk C H; Bank R A; Henskens Y M; Schenkels L C; Ligtenberg A J; Veerman E C
Changes in saliva of epileptic patients.
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 1992;21(5):203-8.
1991: Nieuw Amerongen A V; Oderkerk C H; Veerman E C
Adsorption to hydroxyapatite of partially deglycosylated human salivary mucins in competition with phosvitin and phytate.
Biological chemistry Hoppe-Seyler 1991;372(8):585-91.
1991: Schenkels L C; Rathman W M; Veerman E C; Nieuw Amerongen A V
Detection of proteins related to a salivary glycoprotein (EP-GP). Concentrations in human secretions (saliva, sweat, tears, nasal mucus, cerumen, seminal plasma).
Biological chemistry Hoppe-Seyler 1991;372(5):325-9.
1991: Veerman E C; Valentijn-Benz M; van den Keybus P A; Rathman W M; Sheehan J K; Nieuw Amerongen A V
Immunochemical analysis of high molecular-weight human salivary mucins (MG1) using monoclonal antibodies.
Archives of oral biology 1991;36(12):923-32.
1990: Nieuw Amerongen A V; Oderkerk C H; Veerman E C
Coadsorption onto hydroxyapatite of human salivary mucins and phosvitin, a phosphoprotein from egg yolk.
Journal de biologie buccale 1990;18(2):75-81.
1990: Rathman W M; van Zeyl M J; van den Keijbus P A; Veerman E C; Nieuw Amerongen A V
Comparison of a salivary 14 kD protein displaying cysteine proteinase inhibitory activity with other salivary cystatins.
Journal de biologie buccale 1990;18(1):9-18.
1990: Rathman W M; van den Keybus P A; van Zeyl M J; Döpp E A; Veerman E C; Nieuw Amerongen A V
Characterization of monoclonal antibodies to human salivary (glyco) proteins. Cellular localization of mucin, cystatin-like 14 kD protein and 20 kD glycoprotein in the human submandibular gland.
Journal de biologie buccale 1990;18(1):19-27.
1990: Ligtenberg A J; Veerman E C; de Graaff J; Nieuw Amerongen A V
Influence of the blood group reactive substances in saliva on the aggregation of Streptococcus rattus.
Antonie van Leeuwenhoek 1990;57(2):97-107.
1990: Ligtenberg A J; Veerman E C; de Graaff J; Nieuw Amerongen A V
Saliva-induced aggregation of oral streptococci and the influence of blood group reactive substances.
Archives of oral biology 1990;35 Suppl():141S-143S.
1989: Veerman E C; Valentijn-Benz M; Bank R A; Nieuw Amerongen A V
Isolation of high molecular weight mucins from human whole saliva by ultracentrifugation.
Journal de biologie buccale 1989;17(4):307-12.
1989: Veerman E C; Valentijn-Benz M; Nieuw Amerongen A V
Viscosity of human salivary mucins: effect of pH and ionic strength and role of sialic acid.
Journal de biologie buccale 1989;17(4):297-306.
1989: Rathman W M; Van Zeyl M J; Van den Keybus P A; Bank R A; Veerman E C; Nieuw Amerongen A V
Isolation and characterization of three non-mucinous human salivary proteins with affinity for hydroxyapatite.
Journal de biologie buccale 1989;17(3):199-208.
1989: Nieuw Amerongen A V; Oderkerk C H; Veerman E C
Interaction of human salivary mucins with hydroxyapatite.
Journal de biologie buccale 1989;17(2):85-92.
1988: Nieuw Amerongen A V; Oderkerk C H; Veerman E C
Influence of phytate on the adsorption of human salivary mucins onto hydroxyapatite.
Journal de biologie buccale 1988;16(4):203-8.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Enno Veerman

Research Profile (preview)

Chemicals & Drugs

Anatomy

Genes & Molecular Sequences

Concepts & Ideas

Living Beings

Procedures

Physiology

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Enno Veerman (preview)

All Publications